ESCRS - PO0091 - Corneal Wavefront-Guided Asla With Simultaneous Cxl For 12 Years Post-Hyperopic Lasik Ectasia: 5-Years Follow-Up

Corneal Wavefront-Guided Asla With Simultaneous Cxl For 12 Years Post-Hyperopic Lasik Ectasia: 5-Years Follow-Up

Published 2023 - 41st Congress of the ESCRS

Reference: PO0091 | Type: Case report | DOI: 10.82333/cxh7-fa96

Authors: Ioannis Aslanides 1 , Minas Aslanidis* 2 , Vasileios Selimis 1 , Nan-Ji Lu 3 , Spyros Pipis 2 , Achyut Mukherjee 4

1Ophthalmology,Emmetropia Eye Institute,Heraklion,Greece, 2Ophthalmology,East Suffolk and North Essex NHS Foundation Trust,Colchester,United Kingdom, 3Ophthalmology,Emmetropia Eye Institute,Heraklion,Greece;Faculty of Medicine and Health Sciences,Antwerp,Belgium;Antwerp University Hospital,Antwerp,Belgium, 4Colchester Eye Centre & ICENI Centre,Colchester,United Kingdom

To report the long-term clinical result of a patient diagnosed with bilateral late ectasia after 12 years of hyperopic LASIK correction who received corneal wavefront-guided (CWG)-all surface laser ablation (ASLA) with simultaneous corneal cross-linking (CXL) treatment.

Emmetropia Eye Institute, Heraklion, Greece

A 39 years old patient underwent a bilateral hyperopic microkeratome assisted LASIK in June 2006. From 2010 to 2018, topographical post-hyperopic LASIK ectasia changes and decreased visual acuity were detected and reported in both eyes. Both eyes were treated with CWG-ASLA by sacrificing the corneal flap, combined with simultaneous CXL (30 mW/cm2, 8 minutes pulsed: 1 second on/1 second of, 7.2 J/cm2). Both eyes showed a flattening and stabilized keratometry value and visual acuity at 5 years postoperatively.

Late post-hyperopic LASIK ectasia could occur in patients around 50 years old. Directly performing CWG-ASLA on the corneal flap combined with simultaneous CXL is a safe and effective procedure to treat post-hyperopic LASIK ectasia.